Zejula
My Prescription
Payment
Select pharmacy
$8,929.28
$30.00 due at pharmacy
$8,929.28 - $30.00 = $8,899.28
$8,899.28 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$8,929.28
Print or send this coupon to your phone
AlbertsonsPowered byAbout Zejula
Drug Details
Niraparib, marketed as Zejula, is an oral medication designed to treat adults with advanced ovarian, fallopian tube, or primary peritoneal cancer. It is particularly effective as a maintenance therapy for patients whose cancer has responded to chemotherapy, and it is also beneficial for those with BRCA gene mutations. This targeted treatment works by inhibiting the PARP protein, which is normally responsible for repairing damaged DNA in cells, including cancer cells. By blocking this protein, niraparib prevents cancer cells from repairing themselves, leading to their destruction. Patients typically take one capsule daily. It's important to be aware of serious side effects such as high blood pressure and low blood cell counts. Always consult with your healthcare provider to ensure this treatment is appropriate for you.
Price history for Zejula
30 Capsules, 100MG
Average retail price for Zejula
Average SaveHealth price for Zejula
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Zejula dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 30 Capsules | $8,929.28 | $297.64 |
Zejula FAQs
ZEJULA (niraparib) is not considered traditional chemotherapy. It is classified as a PARP inhibitor, which is a type of targeted therapy used in the treatment of certain types of cancer, such as ovarian cancer. Unlike chemotherapy, which targets rapidly dividing cells, PARP inhibitors specifically target cancer cells with certain genetic mutations.
The cost of ZEJULA can vary based on factors such as insurance coverage, pharmacy, and location. Without insurance, the price can be several thousand dollars per month. Patients are advised to check with their insurance provider for specific coverage details and potential out-of-pocket costs. Additionally, there may be patient assistance programs available to help reduce the cost.
ZEJULA is classified as a poly (ADP-ribose) polymerase (PARP) inhibitor.
Zejula (niraparib) is a medication used as a maintenance treatment for certain types of ovarian, fallopian tube, or primary peritoneal cancer. It works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which can help prevent cancer cells from repairing their DNA, potentially slowing the growth of tumors. While Zejula is not specifically indicated to shrink tumors, it may help in controlling the progression of the disease.
The cost of niraparib can vary based on factors such as location, insurance coverage, and pharmacy. On average, the monthly cost of niraparib without insurance can be several thousand dollars. Patients are encouraged to check with their specific pharmacy and insurance provider for the most accurate pricing and to explore any available financial assistance programs.